BIOMAT Database Logo BIOMAT Database Logo

Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. 1980

G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000637 Transaminases A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1. Aminotransferase,Aminotransferases,Transaminase
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
Seroconversion from hepatitis B e antigen to anti-HBe in acute hepatitis B virus infection.
February 1978, The New England journal of medicine,
G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
Diverse virological, histopathological and prognostic implications of seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.
January 1986, Journal of hepatology,
G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection.
October 2010, Digestive diseases and sciences,
G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
Seroconversion from hepatitis B e antigen in chronic type B hepatitis.
November 1981, Annals of internal medicine,
G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion.
September 2013, Gut,
G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.
June 1981, Annals of internal medicine,
G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
Cytotoxic T cell responses in patients with chronic hepatitis B virus infection undergoing HBe antigen/antibody seroconversion.
November 1995, Clinical and experimental immunology,
G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.
June 1995, Journal of virology,
G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
HBeAg and anti-HBe in chronic hepatitis B virus infection.
April 1981, Gastroenterology,
G Realdi, and A Alberti, and M Rugge, and F Bortolotti, and A M Rigoli, and F Tremolada, and A Ruol
Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview.
January 2003, Journal of hepatology,
Copied contents to your clipboard!